secwatch.observer — SEC 8-K summary
======================================

Issuer:     OPKO HEALTH, INC. (OPK)
CIK:        0000944809
Form:       8-K/A
Filed at:   2024-03-28T23:59:59+00:00
Accession:  0001437749-24-009735
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.50
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OPKO files 8-K/A to update investor presentation after BioReference asset sale to LabCorp
--------------------------------------------------------------------------------

- Asset Purchase Agreement with LabCorp for BioReference Health, LLC signed March 27, 2024.
- This amendment replaces the January investor presentation with a March 27, 2024 version.
- Exhibit 2.1 (Asset Purchase Agreement) filed with schedules omitted; no deal value disclosed.
- No financial or operational details from the updated presentation available in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/944809/000143774924009735/0001437749-24-009735-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/944809/000143774924009735/opk20240328_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-009735

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer